U.S. Capital Wealth Advisors LLC Increases Stake in Counterpoint Quantitative Equity ETF $CPAI

U.S. Capital Wealth Advisors LLC raised its stake in Counterpoint Quantitative Equity ETF (NYSEARCA:CPAI) by 168.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 62,660 shares of the company’s stock after acquiring an additional 39,339 shares during the quarter. U.S. Capital Wealth Advisors LLC owned approximately 2.40% of Counterpoint Quantitative Equity ETF worth $2,330,000 at the end of the most recent reporting period.

Separately, Envestnet Asset Management Inc. acquired a new position in shares of Counterpoint Quantitative Equity ETF in the 1st quarter valued at $442,000.

Counterpoint Quantitative Equity ETF Stock Performance

Shares of NYSEARCA CPAI opened at $39.11 on Wednesday. Counterpoint Quantitative Equity ETF has a 1 year low of $28.48 and a 1 year high of $39.24. The company’s fifty day moving average price is $36.84 and its 200 day moving average price is $35.02. The company has a market capitalization of $105.21 million, a PE ratio of -46,894.48 and a beta of 0.83.

Counterpoint Quantitative Equity ETF Company Profile

The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.